9579-03-31 | ||||
9052-02-14 | ||||
8216-03-09 | ||||
6183-02-26 | ||||
5393-03-07 | ||||
5246-03-21 | ||||
2439-03-19 | ||||
2014-08-05 | Upgrade | Northcoast Research | Neutral to Buy | |
2013-12-27 | Boost Price Target | Wunderlich | Buy | $10.00 to $11.00 |
2013-11-20 | Initiated Coverage | Wunderlich | Buy | $10.00 |
2013-04-11 | Reiterated | The Benchmark Company | Buy | $12 to $16 |
2009-05-01 | Downgrade | Wachovia | Mkt Perform to Underperform | |
2009-01-13 | Upgrade | Wachovia | Underperform to Mkt Perform | |
2008-08-22 | Downgrade | Wachovia | Mkt Perform to Underperform | |
2008-03-24 | Downgrade | Wachovia | Outperform to Mkt Perform | |
2007-04-04 | Upgrade | William Blair | Mkt Perform to Outperform | |
2007-03-13 | Upgrade | Wachovia | Mkt Perform to Outperform | |
1970-01-01 |
9579-03-31 | ||||
9052-02-14 | ||||
8216-03-09 | ||||
6183-02-26 | ||||
5393-03-07 |
There is presents forecasts of rating agencies and recommendations for investors about this ticker
In SMA 0 funds of 2213 total. Show all
Fund name | Ticker shares |
---|
Name Relationship | Total Shares | Holding stocks |
---|---|---|
Moore Brian President Business Development | 0.26% (98020) | SMA / |
Martin D Darin SVP, QA & Regulatory Affairs | 0.21% (80389) | SMA / |
Huntington Christopher William COO, Asia | 0.11% (39444) | SMA / |
CHORMAN THOMAS E | 0.08% (31827) | SMA / SXI / |